: Walgreens sells shares of drug distributor Cencora

Drugstore chain Walgreens Boots Alliance Inc. WBA on Thursday said it had sold shares of drug distributor Cencora Inc. COR for approximately $424 million. Walgreens also entered into a share repurchase by Cencora, formerly known as AmerisourceBergen, for proceeds of roughly $250 million. Walgreens said its ownership of Cencora’s common stock fell due to the repurchase by Cencora, “but remains at approximately 15%.” The drugstore chain said it planned to use the proceeds to repay debt and for general business operations. “The transaction is another decisive action to further simplify the company’s portfolio, while improving cash management,” Walgreens said, adding that it “remains fully committed to the strategic, mutually beneficial relationship with Cencora,” a partner with Walgreens since 2013.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

Previous post Earnings Results: Unity Software’s stock skids 15% on revenue miss, uncertain outlook
Next post MarketWatch First Take: Unity Software has a fleeting moment to win back developers — and investors